Reviewed,
UniProtKB/Swiss-Prot Q9NR16 (C163B_HUMAN)
Last modified
January 19, 2010.
Version 65.
History...
Clusters with 100%,
90%,
50% identity |
Documents (6) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Scavenger receptor cysteine-rich type 1 protein M160 Alternative name(s): CD163 antigen-like 1 CD_antigen=CD163b | ||||||
| Gene names |
| ||||||
| Organism | Homo sapiens (Human) [Complete proteome] | ||||||
| Taxonomic identifier | 9606 [NCBI] | ||||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 1453 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Subcellular location | Isoform 1: Cell membrane; Single-pass type I membrane protein Probable. Isoform 2: Cell membrane; Single-pass type I membrane protein Probable. Isoform 3: Secreted Probable. |
| Tissue specificity | Isoform 1 is highly expressed in the spleen, lymph nodes, thymus, and fetal liver and weakly expressed in bone marrow and no expression was found in peripheral blood leukocytes. Isoform 1 expression is restricted to the monocyte and macrophage cell lines. Isoform 2 is only expressed in spleen. Ref.1 |
| Sequence similarities | Contains 12 SRCR domains. |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Cell membrane Membrane Secreted |
| Coding sequence diversity | Alternative splicing Polymorphism |
| Domain | Repeat Signal Transmembrane |
| PTM | Disulfide bond Glycoprotein |
| Technical term | Complete proteome Direct protein sequencing |
| Gene Ontology (GO) | |
| Cellular component | extracellular region Inferred from electronic annotation. Source: UniProtKB-SubCell integral to membraneInferred from electronic annotation. Source: UniProtKB-SubCell plasma membraneInferred from electronic annotation. Source: UniProtKB-KW |
| Molecular function | scavenger receptor activity Inferred from electronic annotation. Source: InterPro |
| Complete GO annotation... | |
Alternative products
| This entry describes 3 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q9NR16-1) Also known as: M160-alpha; This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q9NR16-2) Also known as: M160-beta; The sequence of this isoform differs from the canonical sequence as follows: 1395-1426: Missing. | ||||||
| Isoform 3 (identifier: Q9NR16-3) The sequence of this isoform differs from the canonical sequence as follows: 718-727: GWGMNIAEVV → SFLMTSSKPR 728-1453: Missing. | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||
Molecule processing | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 40 | 40 | Ref.3 | ||||||||
| Chain | 41 – 1453 | 1413 | Scavenger receptor cysteine-rich type 1 protein M160 | PRO_0000045392 | |||||||
Regions | |||||||||||
| Topological domain | 41 – 1359 | 1319 | Extracellular Potential | ||||||||
| Transmembrane | 1360 – 1380 | 21 | Potential | ||||||||
| Topological domain | 1381 – 1453 | 73 | Cytoplasmic Potential | ||||||||
| Domain | 48 – 148 | 101 | SRCR 1 | ||||||||
| Domain | 155 – 255 | 101 | SRCR 2 | ||||||||
| Domain | 262 – 362 | 101 | SRCR 3 | ||||||||
| Domain | 369 – 469 | 101 | SRCR 4 | ||||||||
| Domain | 476 – 576 | 101 | SRCR 5 | ||||||||
| Domain | 583 – 683 | 101 | SRCR 6 | ||||||||
| Domain | 690 – 790 | 101 | SRCR 7 | ||||||||
| Domain | 795 – 895 | 101 | SRCR 8 | ||||||||
| Domain | 900 – 1000 | 101 | SRCR 9 | ||||||||
| Domain | 1036 – 1136 | 101 | SRCR 10 | ||||||||
| Domain | 1141 – 1243 | 103 | SRCR 11 | ||||||||
| Domain | 1246 – 1346 | 101 | SRCR 12 | ||||||||
Amino acid modifications | |||||||||||
| Glycosylation | 42 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 78 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 120 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 161 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 334 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 377 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 441 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 548 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 637 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 972 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 1013 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 1084 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 1104 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 1161 | 1 | N-linked (GlcNAc...) Ref.4 | ||||||||
| Glycosylation | 1171 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 1318 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 1354 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Disulfide bond | 73 ↔ 137 | By similarity | |||||||||
| Disulfide bond | 86 ↔ 147 | By similarity | |||||||||
| Disulfide bond | 117 ↔ 127 | By similarity | |||||||||
| Disulfide bond | 180 ↔ 244 | By similarity | |||||||||
| Disulfide bond | 193 ↔ 254 | By similarity | |||||||||
| Disulfide bond | 224 ↔ 234 | By similarity | |||||||||
| Disulfide bond | 287 ↔ 351 | By similarity | |||||||||
| Disulfide bond | 300 ↔ 361 | By similarity | |||||||||
| Disulfide bond | 331 ↔ 341 | By similarity | |||||||||
| Disulfide bond | 394 ↔ 458 | By similarity | |||||||||
| Disulfide bond | 407 ↔ 468 | By similarity | |||||||||
| Disulfide bond | 438 ↔ 448 | By similarity | |||||||||
| Disulfide bond | 501 ↔ 565 | By similarity | |||||||||
| Disulfide bond | 514 ↔ 575 | By similarity | |||||||||
| Disulfide bond | 545 ↔ 555 | By similarity | |||||||||
| Disulfide bond | 608 ↔ 672 | By similarity | |||||||||
| Disulfide bond | 621 ↔ 682 | By similarity | |||||||||
| Disulfide bond | 652 ↔ 662 | By similarity | |||||||||
| Disulfide bond | 715 ↔ 779 | By similarity | |||||||||
| Disulfide bond | 728 ↔ 789 | By similarity | |||||||||
| Disulfide bond | 759 ↔ 769 | By similarity | |||||||||
| Disulfide bond | 820 ↔ 884 | By similarity | |||||||||
| Disulfide bond | 833 ↔ 894 | By similarity | |||||||||
| Disulfide bond | 864 ↔ 874 | By similarity | |||||||||
| Disulfide bond | 925 ↔ 989 | By similarity | |||||||||
| Disulfide bond | 938 ↔ 999 | By similarity | |||||||||
| Disulfide bond | 969 ↔ 979 | By similarity | |||||||||
| Disulfide bond | 1061 ↔ 1125 | By similarity | |||||||||
| Disulfide bond | 1074 ↔ 1135 | By similarity | |||||||||
| Disulfide bond | 1105 ↔ 1115 | By similarity | |||||||||
| Disulfide bond | 1181 ↔ 1242 | By similarity | |||||||||
| Disulfide bond | 1212 ↔ 1222 | By similarity | |||||||||
| Disulfide bond | 1271 ↔ 1335 | By similarity | |||||||||
| Disulfide bond | 1284 ↔ 1345 | By similarity | |||||||||
| Disulfide bond | 1315 ↔ 1325 | By similarity | |||||||||
Natural variations | |||||||||||
| Alternative sequence | 718 – 727 | 10 | GWGMNIAEVV → SFLMTSSKPR in isoform 3. | VSP_016875 | |||||||
| Alternative sequence | 728 – 1453 | 726 | Missing in isoform 3. | VSP_016876 | |||||||
| Alternative sequence | 1395 – 1426 | 32 | Missing in isoform 2. | VSP_016877 | |||||||
| Natural variant | 523 | 1 | M → L: dbSNP rs6488268. | VAR_059810 | |||||||
| Natural variant | 578 | 1 | D → N: dbSNP rs4072797. | VAR_057206 | |||||||
| Natural variant | 582 | 1 | G → A: dbSNP rs4072796. | VAR_057207 | |||||||
| Natural variant | 1055 | 1 | G → S: dbSNP rs36206713. | VAR_057208 | |||||||
| Natural variant | 1108 | 1 | M → T: dbSNP rs35480970. | VAR_057209 | |||||||
Sequences
| ||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Cloning of a novel scavenger receptor cysteine-rich type I transmembrane molecule (M160) expressed by human macrophages." Groenlund J., Vitved L., Lausen M., Skjoedt K., Holmskov U. J. Immunol. 165:6406-6415(2000) [PubMed: 11086079] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), TISSUE SPECIFICITY. |
| [2] | "The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment." Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J., Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P., Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E. Gray A.M.Genome Res. 13:2265-2270(2003) [PubMed: 12975309] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3). |
| [3] | "Signal peptide prediction based on analysis of experimentally verified cleavage sites." Zhang Z., Henzel W.J. Protein Sci. 13:2819-2824(2004) [PubMed: 15340161] [Abstract] Cited for: PROTEIN SEQUENCE OF 41-55. |
| [4] | "Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry." Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H. J. Proteome Res. 8:651-661(2009) [PubMed: 19159218] [Abstract] Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-1161, MASS SPECTROMETRY. Tissue: Liver. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AF264014 mRNA. Translation: AAF91396.1. AY358856 mRNA. Translation: AAQ89215.1. |
| IPI | IPI00657946. IPI00658056. IPI00942499. |
| RefSeq | NP_777601.2. |
| UniGene | Hs.631727 |
3D structure databases | |
| SMR | Q9NR16. Positions 1031-1141, 1243-1349. |
| ModBase | Search... |
PTM databases | |
| PhosphoSite | Q9NR16. |
Proteomic databases | |
| PRIDE | Q9NR16. |
Genome annotation databases | |
| Ensembl | ENST00000313599; ENSP00000315945; ENSG00000177675; Homo sapiens. [Genome view] |
| GeneID | 283316. |
| KEGG | hsa:283316. |
Organism-specific databases | |
| CTD | 283316. |
| GeneCards | GC12M007399. |
| H-InvDB | HIX0018278. |
| HGNC | HGNC:30375. CD163L1. |
| HPA | HPA015663. |
| MIM | 606079. gene. |
| PharmGKB | PA142672145. |
| GenAtlas | Search... |
Phylogenomic databases | |
| HOVERGEN | Q9NR16. |
| InParanoid | Q9NR16. |
Gene expression databases | |
| ArrayExpress | Q9NR16. |
| Bgee | Q9NR16. |
| CleanEx | HS_CD163L1. |
| Genevestigator | Q9NR16. |
| GermOnline | ENSG00000177675. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR001190. Srcr_rcpt. IPR017448. Srcr_rcpt-rel. [Graphical view] |
| Pfam | PF00530. SRCR. 12 hits. [Graphical view] |
| PRINTS | PR00258. SPERACTRCPTR. |
| SMART | SM00202. SR. 12 hits. [Graphical view] |
| PROSITE | PS00420. SRCR_1. 5 hits. PS50287. SRCR_2. 12 hits. [Graphical view] |
| ProtoNet | Search... |
Other Resources | |
| NextBio | 93813. |
| SOURCE | Search... |
Entry information
| Entry name | C163B_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9NR16 Secondary accession number(s): Q6UWC2 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human cell differentiation molecules CD nomenclature of surface proteins of human leucocytes and list of entries |
| Human chromosome 12 Human chromosome 12: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with


